Back

Levosimendan in heart transplantation: a systemic review and meta-analysis

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk stratification in heart transplantation and beyond Heart Transplantation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Mohammad Altermanini

Heart Hospital, Doha (Qatar)

Photo
Doctor Rasha Kaddoura

HMC Heart Hospital, Doha (Qatar)

6 More presentations in this session

Presentation thumbnail
The role of immunoglobulins and inflammatory markers in donor heart graft selection
Doctor K. Fozilov (Tashkent, UZ)
Presentation thumbnail
Patient preferences for heart failure medications: a discrete choice experiment
Doctor R. Turgeon (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Effectiveness of multidisciplinary disease management for patients with heart failure: a systematic review and meta-analysis
Doctor M. Shimbo (Fuchu, JP)
Abstract Slides Video
Presentation thumbnail
Relevance of traditional cardiovascular risk factors for the development of cardiac allograft vasculopathy– a meta-analysis
Doctor C. Moos (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
ACG risk stratification population-based high-risk heart failure patients’ identification
Professor A. Sousa (Santa Maria da Feira, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in heart transplantation and beyond

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Everolimus-based immunosuppression in heart transplantation reduces cardiac allograft vasculopathy progression and preserves renal function: a systematic review and meta-analysis
30 August 2026
thumbnail
Congress Presentation
Intermittent levosimendan infusions for advanced heart failure: a systematic review and meta-analysis of randomized controlled trials.
31 August 2024
thumbnail
Congress Presentation
Levosimendan in patients undergoing cardiac surgery: does timing matter?
18 March 2022
thumbnail
Congress Presentation
Destination therapy strategies of advanced heart failure in elderly non-heart transplant candidates: A propensity matching analysis from the LEVO-D and REGALAD registries.
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources